Related references
Note: Only part of the references are listed.Oxidative stress contributes differentially to the pathophysiology of Charcot-Marie-Tooth disease type 2K
Julien Cassereau et al.
EXPERIMENTAL NEUROLOGY (2020)
The role of microtubules in secretory protein transport
Lou Fourriere et al.
JOURNAL OF CELL SCIENCE (2020)
Structural and functional divergence of GDAP1 from the glutathione S-transferase superfamily
Matthew R. Googins et al.
FASEB JOURNAL (2020)
Selective fragmentation of the trans-Golgi apparatus by Rickettsia rickettsii
Karin Aistleitner et al.
PLOS PATHOGENS (2020)
Pathogenic Effect of GDAP1 Gene Mutations in a Yeast Model
Weronika Rzepnikowska et al.
GENES (2020)
Flavonoids as Potential Drugs for VPS13-Dependent Rare Neurodegenerative Diseases
Piotr Soczewka et al.
GENES (2020)
Golgi Apparatus: An Emerging Platform for Innate Immunity
Ye Tao et al.
TRENDS IN CELL BIOLOGY (2020)
Golgi Fragmentation in Neurodegenerative Diseases: Is There a Common Cause?
Jose Angel Martinez-Menarguez et al.
CELLS (2019)
Neuroinflammation in the pathogenesis of axonal Charcot-Marie-Tooth disease caused by lack of GDAP1
Sara Fernandez-Lizarbe et al.
EXPERIMENTAL NEUROLOGY (2019)
Characterization of molecular mechanisms underlying the axonal Charcot-Marie-Tooth neuropathy caused by MORC2 mutations
Paula Sancho et al.
HUMAN MOLECULAR GENETICS (2019)
Calcium Deregulation and Mitochondrial Bioenergetics in GDAP1-Related CMT Disease
Paloma Gonzalez-Sanchez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A role for the GDAP1 gene in the molecular pathogenesis of Charcot-Marie-Tooth disease
Weronika Rzepnikowska et al.
ACTA NEUROBIOLOGIAE EXPERIMENTALIS (2018)
Parkinson's disease-associated mutant LRRK2 phosphorylates Rab7L1 and modifies trans-Golgi morphology
Tetta Fujimoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation
Jueqi Chen et al.
NATURE (2018)
Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs
Kurt R. Brunden et al.
NEUROBIOLOGY OF DISEASE (2017)
Phenotypical features of a new dominant GDAP1 pathogenic variant (p.R226de1) in axonal Charcot-Marie-Tooth disease
Tania Garcia-Sobrino et al.
NEUROMUSCULAR DISORDERS (2017)
CMT-linked loss-of-function mutations in GDAP1 impair store-operated Ca2+ entry-stimulated respiration
Paloma Gonzalez-Sanchez et al.
SCIENTIFIC REPORTS (2017)
Lack of GDAP1 Induces Neuronal Calcium and Mitochondrial Defects in a Knockout Mouse Model of Charcot-Marie-Tooth Neuropathy
Manuela Barneo-Munoz et al.
PLOS GENETICS (2015)
Junctophilin-1 is a modifier gene of GDAP1-related Charcot-Marie-Tooth disease
David Pla-Martin et al.
HUMAN MOLECULAR GENETICS (2015)
Truncating and Missense Mutations in IGHMBP2 Cause Charcot-Marie Tooth Disease Type 2
Ellen Cottenie et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2014)
A Role of Rab29 in the Integrity of the Trans-Golgi Network and Retrograde Trafficking of Mannose-6-Phosphate Receptor
Shicong Wang et al.
PLOS ONE (2014)
Charcot-Marie-Tooth disease-associated mutants of GDAP1 dissociate its roles in peroxisomal and mitochondrial fission
Nina Huber et al.
EMBO REPORTS (2013)
Sh3tc2 deficiency affects neuregulin-1/ErbB signaling
Estelle Arnaud Gouttenoire et al.
GLIA (2013)
Silencing of the Charcot-Marie-Tooth disease-associated gene GDAP1 induces abnormal mitochondrial distribution and affects Ca2+ homeostasis by reducing store-operated Ca2+ entry
David Pla-Martin et al.
NEUROBIOLOGY OF DISEASE (2013)
Charcot-Marie-Tooth disease CMT4A: GDAP1 increases cellular glutathione and the mitochondrial membrane potential
Rebecca Noack et al.
HUMAN MOLECULAR GENETICS (2012)
Local control of phosphatidylinositol 4-phosphate signaling in the Golgi apparatus by Vps74 and Sac1 phosphoinositide phosphatase
Christopher S. Wood et al.
MOLECULAR BIOLOGY OF THE CELL (2012)
A new missense GDAP1 mutation disturbing targeting to the mitochondrial membrane causes a severe form of AR-CMT2C disease
Dagmara Kabzinska et al.
NEUROGENETICS (2011)
Dominant GDAP1 mutations cause predominantly mild CMT phenotypes
M. Zimon et al.
NEUROLOGY (2011)
A yeast-based assay identifies drugs active against human mitochondrial disorders
Elodie Couplan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
L239F founder mutation in GDAP1 is associated with a mild Charcot-Marie-Tooth type 4C4 (CMT4C4) phenotype
Dagmara Kabzinska et al.
NEUROGENETICS (2010)
Dynamin 2 Mutations Associated With Human Diseases Impair Clathrin-Mediated Receptor Endocytosis
Marc Bitoun et al.
HUMAN MUTATION (2009)
GDAP1 mutations differ in their effects on mitochondrial dynamics and apoptosis depending on the mode of inheritance
Axel Niemann et al.
NEUROBIOLOGY OF DISEASE (2009)
Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K)
Julien Cassereau et al.
NEUROGENETICS (2009)
Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy
Teresa Sevilla et al.
BRAIN (2008)
Cell expression of GDAP1 in the nervous system and pathogenesis of Charcot-Marie-Tooth type 4A disease
Laia Pedrola et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Activation of ADP-ribosylation factor regulates biogenesis of the ATP7A-containing trans-Golgi network compartment and its Cu-induced trafficking
Zoe G. Holloway et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Regulation of the transport and protein levels of the inositol phosphorylceramide mannosyltransferases Csg1 and Csh1 by the Ca2+ binding protein Csg2
Satoshi Uemura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy
Gerd Meyer zu Horste et al.
ANNALS OF NEUROLOGY (2007)
Functional characterisation of ganglioside-induced differentiation-associated protein 1 as a glutathione transferase
Alison J. Shield et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Live imaging of yeast Golgi cisternal maturation
Kumi Matsuura-Tokita et al.
NATURE (2006)
Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease
A Niemann et al.
JOURNAL OF CELL BIOLOGY (2005)
GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria
L Pedrola et al.
HUMAN MOLECULAR GENETICS (2005)
Domains of the TGN: Coats, tethers and G proteins
PA Gleeson et al.
TRAFFIC (2004)
Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease
E Passage et al.
NATURE MEDICINE (2004)
Evolutionary and structural analyses of GDAP1, involved in Charcot-Marie-Tooth disease, characterize a novel class of glutathione transferase-related genes
A Marco et al.
MOLECULAR BIOLOGY AND EVOLUTION (2004)
Isolation of 10 Differentially Expressed cDNAs in Differentiated Neuro2a Cells Induced Through Controlled Expression of the GD3 Synthase Gene
Hong Liu et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Isolation of drugs active against mammalian prions using a yeast-based screening assay
S Bach et al.
NATURE BIOTECHNOLOGY (2003)
The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease
A Cuesta et al.
NATURE GENETICS (2002)
Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21
RV Baxter et al.
NATURE GENETICS (2002)
Share Paper
